125 related articles for article (PubMed ID: 3113511)
41. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor.
Blay JY; Burdin N; Rousset F; Lenoir G; Biron P; Philip T; Banchereau J; Favrot MC
Blood; 1993 Oct; 82(7):2169-74. PubMed ID: 8400266
[TBL] [Abstract][Full Text] [Related]
42. Treatment of children and adolescents with non-Hodgkin's lymphoma (results based on the NHL Berlin-Frankfurt-Münster 90 protocols).
Kavan P; Kabicková E; Gajdos P; Koutecký J; Smelhaus V; Stanková J; McClain KL
Cas Lek Cesk; 1999 Jan; 138(2):40-6. PubMed ID: 10376402
[TBL] [Abstract][Full Text] [Related]
43. Childhood non-Hodgkin's lymphoma: an immunophenotypic analysis.
Shah SH; Muzaffar S; Pervez S; Hassan SH
J Pak Med Assoc; 2000 Mar; 50(3):89-91. PubMed ID: 10795468
[TBL] [Abstract][Full Text] [Related]
44. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
Kalmanti M; Karamolengou K; Dimitriou H; Tosca A; Vlachonikolis I; Peraki M; Georgoulias V; Kalmantis T
Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
[TBL] [Abstract][Full Text] [Related]
45. High serum hepatocyte growth factor level in patients with non-Hodgkin's lymphoma.
Hsiao LT; Lin JT; Yu IT; Chiou TJ; Liu JH; Yen CC; Wang WS; Chen PM
Eur J Haematol; 2003 May; 70(5):282-9. PubMed ID: 12694163
[TBL] [Abstract][Full Text] [Related]
46. Treatment of advanced stage diffuse, small non-cleaved cell lymphoma in childhood: further experience with total therapy B.
Griffin TC; Bowman WP; Winick NJ; Buchanan GR
Med Pediatr Oncol; 1994; 23(5):393-9. PubMed ID: 8084306
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis C Virus and related changes in immunological parameters in non Hodgkin's lymphoma patients.
el-Din HM; Attia MA; Hamza MR; Khaled HM; Thoraya MA; Eisa SA
Egypt J Immunol; 2004; 11(1):55-64. PubMed ID: 15724387
[TBL] [Abstract][Full Text] [Related]
48. [Primary study of relationship between serum level of VEGF and non-Hodgkin's lymphoma in children and adolescent patients].
Xia Y; Sun XF; Zhang CQ; Zhen ZJ; Wang ZH; Wang ZQ
Ai Zheng; 2004 Nov; 23(11 Suppl):1448-50. PubMed ID: 15566654
[TBL] [Abstract][Full Text] [Related]
49. Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: A report from the Korean society of pediatric hematology-oncology.
Won SC; Han JW; Kwon SY; Shin HY; Ahn HS; Hwang TJ; Yang WI; Lyu CJ
Ann Hematol; 2006 Nov; 85(11):787-94. PubMed ID: 16932891
[TBL] [Abstract][Full Text] [Related]
50. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
[TBL] [Abstract][Full Text] [Related]
51. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
[TBL] [Abstract][Full Text] [Related]
52. Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin's lymphoma.
Stasi R; Zinzani L; Galieni P; Lauta VM; Damasio E; Dispensa E; Dammacco F; Venditti A; Del Poeta G; Cantonetti M
Eur J Haematol; 1995 Jan; 54(1):9-17. PubMed ID: 7859883
[TBL] [Abstract][Full Text] [Related]
53. Clinical implications of serum levels of soluble CD23 and tumor necrosis factor alpha in low-grade non-Hodgkin's lymphoma.
Zinzani PL; Baccini C; Zaccaria A; Visani G; Buzzi M; Morelli A; Molinari AL; Salvucci M; Bendandi M; Rubboli D; Gherlinzoni F; Zanchini R; Tura S
Eur J Haematol; 1996 Nov; 57(5):335-40. PubMed ID: 9003473
[TBL] [Abstract][Full Text] [Related]
54. Childhood non-Hodgkin's lymphoma--results of treatment with ALL high-risk protocol.
Chu HY; Shu SG; Law KL; Chi CS
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993; 34(2):118-24. PubMed ID: 8372667
[TBL] [Abstract][Full Text] [Related]
55. Clinical and prognostic analysis of 125 cases of non-Hodgkin's lymphoma.
Liu L; Zhang M; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):547-50. PubMed ID: 18549626
[TBL] [Abstract][Full Text] [Related]
56. [Serum tumor necrosis factor-alpha levels in non-Hodgkin's lymphoma patients and its relationship to prognosis].
Li D; Li G; Wang B
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):293-6. PubMed ID: 11038763
[TBL] [Abstract][Full Text] [Related]
57. Serum LDH values in childhood acute leukemias and non-Hodgkin's lymphoma.
Suarez CR; Andreeff M; Miller DR
Med Pediatr Oncol; 1984; 12(2):89-92. PubMed ID: 6583472
[TBL] [Abstract][Full Text] [Related]
58. Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report.
Lones MA; Perkins SL; Sposto R; Tedeschi N; Kadin ME; Kjeldsberg CR; Wilson JF; Zwick DL; Cairo MS
J Clin Oncol; 2002 May; 20(9):2293-301. PubMed ID: 11981000
[TBL] [Abstract][Full Text] [Related]
59. Increased levels of soluble interleukin-2 receptor in non-Hodgkin's lymphomas. Relationship with clinical, histologic, and phenotypic features.
Chilosi M; Semenzato G; Vinante F; Menestrina F; Piazzola E; Focchiatti V; Sabbioni R; Zanotti R; Pizzolo G
Am J Clin Pathol; 1989 Aug; 92(2):186-91. PubMed ID: 2667328
[TBL] [Abstract][Full Text] [Related]
60. Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2Rα) in patients with non-Hodgkin's lymphoma.
Jo SA; Hwang SH; Chang CL; Kim SY; Shin HJ; Chung JS; Sol MY; Lee EY
Korean J Lab Med; 2010 Dec; 30(6):600-5. PubMed ID: 21157146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]